Details of the Drug

General Information of Drug (ID: DMIYBGZ)

Drug Name

NPS-31807

Synonyms

PP-05; TNF alpha modulator (inflammation), Piramal Life Sciences; TNF alpha modulator (inflammation), NPIL Research & Development

Indication

Disease Entry	ICD 11	Status	REF
Psoriasis vulgaris	EA90	Phase 4	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01373567) A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis. U.S. National Institutes of Health.